significantly higher than chronological age in patients with ischemia. On the other hand, it was significantly lower than chronological age in those without ischemia. Using incremental analysis, vascular age was more predictive of the presence of myocardial ischemia than chronological age. What is the clinical relevance of these findings?
Chronological age is an easy and long-standing risk marker that is used intuitively on routine basis whenever we evaluate patients for suspected CAD. Is it a perfect marker? Of course not, just like all other known CAD risk factors. Every physician who has been long enough in clinical practice will remember cases of patients who were old, smokers, diabetic, hypertensive, smokers and yet had no obstructive CAD at all when they had a coronary angiogram. On the other hand, they would also remember young patients presenting with acute myocardial infarction with no risk factors at all and with a CAC score of zero. This implies that our assessment of patients should not simply rely on a marker or a risk model but on sound clinical judgment that is guided (but not completely driven) by all of these risk factors, models, and imaging tools. To come back to the findings of Nappi et al., we know for a long time that chronological age and CAC score are both individual markers of myocardial ischemia. 7 It is therefore not surprising that a combination of these two markers will be even a better marker of myocardial ischemia. It is also not surprising that the combination of these two markers would be a better marker of cardiovascular risk in general. But does that mean that we should drop chronological age in our routine clinical assessment and replace it with ''Vascular age''? This would be a big leap, especially that this argument could be extrapolated to other risk factors as well. A 40-year-old man with diabetes would have a higher cardiovascular risk than a 40-year-old man without diabetes. Does that mean that we should have a ''Diabetic age'' to adjust the age of a patient for the presence or absence of diabetes?
The findings of Nappi et al. are important and add to our understanding of the wide spectrum of coronary atherosclerosis with its risk factors and risk assessment models. However, with the increasing number of these models (363 as indicated by Damen et al. 1 ) and of the imaging techniques available for the assessment of patients with suspected CAD, it becomes important for the scientific community to decrease the complexity of this assessment and come up with simple algorithms that can guide the practicing physician as well as the patient in the prevention and treatment of cardiovascular disease.
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